Expression of Concern to: Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition

Benjamin Fourneaux^{1

2}, Aurélien Bourdon², Bérengère Dadone³, Carlo Lucchesi², Scott R Daigle⁴, Elodie Richard^{1

2}, Audrey Laroche-Clary^{1

2}, François Le Loarer⁵, Antoine Italiano^{6

7}

Affiliations

¹ Université de Bordeaux, Bordeaux, France.
² Institut National de la Santé et de la Recherche Medicale (INSERM) U1218, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France.
³ Department of Pathology, Nice University Hospital, Nice, France.
⁴ Epizyme, Inc., Cambridge, MA, USA.
⁵ Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
⁶ Institut National de la Santé et de la Recherche Medicale (INSERM) U1218, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.
⁷ Department of Medical Oncology, Institut Bergonié, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.

Benjamin Fourneaux et al. J Hematol Oncol. 2019.

. 2019 Nov 22;12(1):116.

doi: 10.1186/s13045-019-0825-3.

¹ Université de Bordeaux, Bordeaux, France.
² Institut National de la Santé et de la Recherche Medicale (INSERM) U1218, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France.
³ Department of Pathology, Nice University Hospital, Nice, France.
⁴ Epizyme, Inc., Cambridge, MA, USA.
⁵ Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
⁶ Institut National de la Santé et de la Recherche Medicale (INSERM) U1218, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.
⁷ Department of Medical Oncology, Institut Bergonié, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.

Abstract

The Editor-in-Chief would like to alert readers that the ownership of some of the data presented in this article [1].

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.
Fourneaux B, Bourdon A, Dadone B, Lucchesi C, Daigle SR, Richard E, Laroche-Clary A, Le Loarer F, Italiano A. Fourneaux B, et al. J Hematol Oncol. 2019 Jan 25;12(1):11. doi: 10.1186/s13045-018-0694-1. J Hematol Oncol. 2019. PMID: 30683135 Free PMC article.

1. Fourneaux B, Bourdon A, Dadone B, Lucchesi C, Daigle SR, Richard E, Laroche-Clary A, Le Loarer F, Italiano A. Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition. J Hematol Oncol. 2019;12(1):11. doi: 10.1186/s13045-018-0694-1. - DOI - PMC - PubMed